Local company rings NASDAQ opening bell after $14 million IPO

TAMPA —Officials from Alzamend Neuro were in Times Square Monday morning July 12 to ring the opening bell at the NASDAQ exchange just days shy of the one-month anniversary of its IPO and as it awaits federal approval to begin early study on a drug to treat Alzheimer's Disease.

The team in attendance to ring the bell included company founder and chairman emeritus Milton “Todd” Ault III, CEO Stephan Jackman and board chairman William B. Horne. Alzamend is a Tampa-based preclinical stage biopharmaceutical company that is working on products to treat Alzheimer’s disease and dementia, according to a statement.